Name | Research Code | Research Phase | Company | Indications | Clinical Trials |
---|---|---|---|---|---|
F16 IL2 fusion protein (Philogen) | F-16-IL-2 | Phase 2 Clinical | Philogen | Solid tumours; Carcinoma, Merkel Cell; Hemangiosarcoma; Breast Neoplasms; Leukemia, Myeloid, Acute; Carcinoma, Non-Small-Cell Lung; Melanoma | Details |
This web search service is supported by Google Inc.